RankingsPricing
  1. JP-listed companies
  2. D.Western Therapeutics Institute, Inc.
  3. Financials
  4. Earnings per share

D.Western Therapeutics Institute, Inc.【JP:4576】

Market cap
¥4.8B
P/E ratio
-6.7x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEarnings per share (JPY)YoY (%)
Dec 31, 2024-36.7+43.74%
Dec 31, 2023-25.6+76.28%
Dec 31, 2022-14.5+185.43%
Dec 31, 2021-5.1-50.00%
Dec 31, 2020-10.2-300.39%
Dec 31, 20195.1-117.78%
Dec 31, 2018-28.5-52.40%
Dec 31, 2017-59.9+472.56%
Dec 31, 2016-10.5-19.48%
Dec 31, 2015-13+53.36%
Dec 31, 2014-8.5-19.26%
Dec 31, 2013-10.5-27.61%
Dec 31, 2012-14.5-29.18%
Dec 31, 2011-20.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)